BPC-157 Benefits for Women: What Studies Say

In the majority of studies on BPC-157, only male subjects are investigated. This practice is not confined to BPC-157 studies only but exists in most pharmacological studies. Hence, in the case of women looking into BPC-157 studies, the pertinent question is what information about studies with female models is available, what knowledge gaps exist, and what result from studies with male models can and cannot be applied.

Are BPC-157 Studies Done on Female Animals?

Sex Distribution in Published Protocols

The majority of published BPC-157 studies specify male Wistar or Sprague-Dawley rats. Some studies do not specify sex at all. A 2025 systematic review covering BPC-157 literature did not identify a subset of studies using exclusively female animals. This means the body of evidence is overwhelmingly derived from male models.

It is important to point out that the gap exists because sex hormones have an effect on inflammation as well as collagen production and healing of wounds. Estrogen regulates the production of inflammatory cytokines as well as influencing the laxity of tendons and ligaments. Nevertheless, results obtained in male rats may not necessarily apply to the female physiology.

Gut Health Benefits Relevant to Women

NSAID Use Patterns and Gastric Protection Data

NSAIDs are used more by women than men in terms of diseases such as dysmenorrhea, migraine and autoimmune diseases. The most replicated property of BPC-157 in animal studies is protection against gastric lesions caused by NSAIDs and alcohol. According to 2011 review, the peptide is an anti-ulcer drug with proven efficiency in numerous rat models.

The relevance for women lies in their higher rates of NSAID exposure. The gastroprotection data comes from male rats, so applicability to women is assumed but unproven. There is no experiment that has determined whether the gastroprotective effect of BPC-157 is dependent on sex differences in animal models.

Tendon and Ligament Considerations

Estrogen, Collagen and Injury Risk

Women have higher rates of certain ligament injuries, particularly ACL tears. Fluctuations in estrogen levels across the menstrual cycle affect collagen synthesis and tendon mechanical properties. BPC-157 promoted tendon healing in rat Achilles transection models by increasing load to failure and stimulating tendon fibroblast migration through the FAK-paxillin pathway.

Whether this mechanism interacts with estrogen-mediated collagen pathways is unknown. The tendon studies used male rats. A study in female rats with controlled estrogen levels would be needed to determine if the effect size is the same or different.

What Is NOT Known

No Sex-Specific Human Data

BPC-157 has not been tested in any human population. The absence of sex-specific data is part of the broader absence of human studies on BPC-157. No published evidence supports claims that BPC-157 works differently in men and women.

Pregnancy and Hormonal Interactions - Zero Studies

BPC-157 has not been studied in pregnant animals, and no research explores its interaction with reproductive hormones. No information exists on its effects during lactation, menstrual cycle stages, or contraceptive use. Without data on these subjects, no safety recommendations can be made for women in these situations.